Recruiting
Austrian Registry on Transjugular Intrahepatic Portosystemic Shunts
Patients with TIPS will be recruited in this prospective registry study. The clinical course will be documented and biomarkers for prediction of complicatiosn will be assessed.
ClinicalTrials.gov IDNCT03409263
PhaseNot Applicable
Enrollment400
SponsorThomas Reiberger
Age18 Years
SexALL
Conditions studied
Portal Hypertension
About this study
Patients with TIPS will be recruited in this prospective registry study. The clinical course will be documented and biomarkers for prediction of complicatiosn will be assessed.
Interventions
- Other: Observational study — Not applicable (observational registry study)
Primary outcomes
- Transplant-free survival (0-10 years)
Eligibility information
Inclusion Criteria:
* Age 18-99 years
* Portal hypertension
* Anticipated or past implantation of a transjugular intrahepatic portosystemic shunt (TIPS)
* Informed consent
Exclusion Criteria:
* Retraction of consent
Study locations
- Medical University of Vienna, Vienna, State of Vienna 1090 Austria
Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.